OptiPin
BAM-15: uses, dosing & the facts
A research compound that acts as a mitochondrial uncoupler, increasing energy expenditure and potentially supporting weight loss and metabolic health. This is an evidence-graded reference — what it is, what it's used for, typical reported dosing, half-life, side effects, and how to track it. It is educational, not medical advice or a recommendation to use a research compound.
- • BAM-15 — Fat loss. A research compound that acts as a mitochondrial uncoupler, increasing energy expenditure and potentially supporting weight loss and metabolic health.
- • Commonly used for weight loss support, metabolic health, energy expenditure increase.
- • Half-life: Approximately 4-6 hours.
- • Status: Research use only · not FDA-approved — an educational reference, not a dose protocol or sourcing advice.
What BAM-15 is
A research compound that acts as a mitochondrial uncoupler, increasing energy expenditure and potentially supporting weight loss and metabolic health.
What BAM-15 is used for
- • Weight loss support
- • Metabolic health
- • Energy expenditure increase
- • Mitochondrial function
- • Obesity treatment research
- • Body recomposition
These are reported/community uses, not proven clinical outcomes. Most research peptides have limited human trial data behind such claims.
Typical reported dosing
| Oral | 15-30mg taken orally daily with food |
Presented as commonly-reported patterns for information only — not a dose recommendation. BAM-15 dosing is a decision for a qualified clinician.
Half-life & cycling
Half-life: Approximately 4-6 hours. Half-life drives dosing frequency and how quickly the compound clears — see it plotted on the half-life visualizer.
Cycling
Can be used continuously during weight loss periods. Typical cycles: 8-12 weeks on, 4 weeks off. Monitor closely.
Side effects & warnings
- • Generally well-tolerated
- • Possible increased body temperature
- • Possible mild gastrointestinal effects
- • Limited long-term safety data
Research use only. Very new research compound with limited human data. Mitochondrial uncoupler - monitor body temperature. May increase energy expenditure significantly. Start with lower doses (15mg). Not technically a peptide but often grouped with research compounds.
Tracking BAM-15 in OptiPin
If you're tracking a BAM-15 protocol, OptiPin logs each dose with reminders and site rotation, charts the outcome you care about over your dose timeline, keeps per-vial inventory with runout warnings, and (where relevant) does the reconstitution math — all on-device, no account.
Log doses, outcomes & vials in OptiPin
Reminders, outcome-over-dose charts, vial runout warnings, and built-in reconstitution math — all on-device.
Download on the App StoreFAQ
What is BAM-15?
A research compound that acts as a mitochondrial uncoupler, increasing energy expenditure and potentially supporting weight loss and metabolic health.
What is BAM-15 used for?
Commonly discussed uses include: weight loss support, metabolic health, energy expenditure increase, mitochondrial function, obesity treatment research, body recomposition. These are reported uses, not proven outcomes or a recommendation.
How is BAM-15 dosed?
Commonly reported dosing: Oral — 15-30mg taken orally daily with food. This reflects patterns discussed in the community and is presented for information only, not as a dose recommendation — BAM-15 is not an approved medicine and dosing should involve a qualified clinician.
What is BAM-15's half-life?
Approximately 4-6 hours. Half-life shapes how often it is dosed and how quickly it clears.
What are BAM-15's side effects?
Reported effects include: generally well-tolerated, possible increased body temperature, possible mild gastrointestinal effects, limited long-term safety data. Because it is a research compound, its safety profile is not fully characterized; discuss risks with a clinician.
Evidence & further reading
- Search the peer-reviewed literature for BAM-15 on PubMed (entry point to the primary evidence base, not a specific citation).
- BAM-15 on ClinicalTrials.gov — registered human trials, if any.
- US FDA / 503A compounding status of research peptides (2026).
- OptiPin peptides guide — categories, evidence grading, and how to run a protocol honestly.
Related
Cagrilintide · Frag 176-191 · MOTS-C · SLU-PP-332 · Tirzepatide (Mounjaro/Zepbound) · Reconstitution calculator · All peptides